ClinRheumatol Profile Banner
ClinRheumatol Profile
ClinRheumatol

@ClinRheumatol

Followers
8K
Following
219
Statuses
762

Clinical Rheumatology - Journal of the International League of Associations for Rheumatology 2023 Impact Factor: 2.9 Editor-in-Chief: Prof. Adewale Adebajo

Joined August 2019
Don't wanna be here? Send us removal request.
@ClinRheumatol
ClinRheumatol
16 hours
Late-onset #AxialSpondyloarthritis #AxSpA: data from Reuma-check cohort by @RodrigoGSalinas and colleagues @sofiaramiro82 πŸ‘‰
@ClinRheumatol
ClinRheumatol
2 days
Late-Onset #AxSpA (lo-axSpA): A Distinct Subgroup? πŸ‘‰ πŸ“Š Key findings from the Reuma-check cohort: βœ”οΈ 28% of axSpA cases started at β‰₯45 years. βœ”οΈ More common in females (51%) & psoriasis (42%). βœ”οΈ Lower NSAID response (52%) & HLA-B27 positivity (32%). βœ”οΈ Shorter diagnosis delay (40 vs. 93 months) than early-onset axSpA ⚠️ lo-axSpA may require distinct diagnostic & treatment approaches.
Tweet media one
0
3
9
@ClinRheumatol
ClinRheumatol
2 days
Late-Onset #AxSpA (lo-axSpA): A Distinct Subgroup? πŸ‘‰ πŸ“Š Key findings from the Reuma-check cohort: βœ”οΈ 28% of axSpA cases started at β‰₯45 years. βœ”οΈ More common in females (51%) & psoriasis (42%). βœ”οΈ Lower NSAID response (52%) & HLA-B27 positivity (32%). βœ”οΈ Shorter diagnosis delay (40 vs. 93 months) than early-onset axSpA ⚠️ lo-axSpA may require distinct diagnostic & treatment approaches.
Tweet media one
0
21
49
@ClinRheumatol
ClinRheumatol
2 days
Take a look at the February issue of Clinical Rheumatology! Explore the newest articles and updates πŸ‘‰
Tweet media one
0
7
22
@ClinRheumatol
ClinRheumatol
14 days
How do ILAR & PRINTO classifications impact #JIA diagnosis and treatment? πŸ‘‰ βœ…Age & ANA positivity (β‰₯1/160) improve consistency in assessing uveitis risk & treatment response βœ…One positive ANA test may be enoughβ€”no need for repeat testing βœ… Early bDMARDs treatment may benefit ANA-positive JIA patients βœ…PRINTO’s β€œother JIA” category needs further refinement for clinical use
Tweet media one
0
5
10
@ClinRheumatol
ClinRheumatol
17 days
πŸ“’ New Review on Ectopic Calcifications in the Musculoskeletal Field βœ… Mechanisms of soft-tissue calcifications βœ… Pharmacological strategies: NSAIDs, corticosteroids, bisphosphonates, vitamin K2+D βœ… Balancing #calcification inhibition with bone health πŸ‘‰
Tweet media one
0
5
9
@ClinRheumatol
ClinRheumatol
22 days
Refractory #PsoriaticArthritis #PsA: πŸ” Lack of consensus on definition. βœ… Authors propose two categories: πŸ“ŒD2T PsA: persistent despite treatment. πŸ“ŒPseudo-D2T PsA: misdiagnosis or mismanagement. Clear distinctions can improve care! πŸ‘‰
Tweet media one
0
13
22
@ClinRheumatol
ClinRheumatol
22 days
πŸ”₯NEWπŸ”₯ Refractory #PsoriaticArthritis: emerging concepts in whole process management πŸ‘‰ πŸ“ŒPhases of #PsA development and strategies for prevention πŸ‘‡
Tweet media one
0
22
38
@ClinRheumatol
ClinRheumatol
22 days
πŸ”₯New Editorial to read! πŸ‘‰ Explore strategies for tailored #PatientEducation to boost adherence, improve outcomes, and tackle challenges in biologic therapy. #biologics #rheumatology
Tweet media one
0
8
11
@ClinRheumatol
ClinRheumatol
1 month
Take a look at the January issue of Clinical Rheumatology! Explore the newest articles and updates. πŸ‘‰
Tweet media one
0
4
10
@ClinRheumatol
ClinRheumatol
1 month
New Study Highlights Urgent Need for #Rheumatology #Education in Medical Schools. πŸ” Teaching hours: 4–120 globally πŸ“‰ Limited exposure impacts awareness & recruitment πŸ“š Standardized curricula needed for rising rheumatic disease burden
Tweet media one
0
4
17
@ClinRheumatol
ClinRheumatol
2 months
πŸŽ„ Thank you to our readers, authors, and reviewers for your invaluable contributions this year. Your dedication helps us advance the field of #rheumatology and improve patient care worldwide. Wishing you a joyful holiday season and a successful New Year! πŸŒŸβ„οΈπŸŽ„
Tweet media one
0
4
20
@ClinRheumatol
ClinRheumatol
2 months
🌟 A New Era for Clinical Rheumatology! We are excited to share the first editorial by our Editor-in-Chief, Prof. Adewale Adebajo, marking a new chapter for the journal. "Together, we advance research, education, and innovation in rheumatology worldwide!" πŸ”—
Tweet media one
0
5
16
@ClinRheumatol
ClinRheumatol
2 months
πŸ₯— Can diet impact #RheumatoidArthritis? πŸ₯© New study finds: βœ…A low-carbohydrate diet (LCD) may reduce #RA risk. βœ…High protein intake is linked to a lower likelihood of RA. πŸ”— #Diet
Tweet media one
0
7
18
@ClinRheumatol
ClinRheumatol
2 months
#Frailty and pre-frailty are common in #SystemicSclerosis #SSc πŸ”Ή 14% frail, 53% pre-frail πŸ”Ή ↑ risk of mortality, ↓ quality of life πŸ”Ή Key drivers: cardiopulmonary disease, inflammation & age πŸ””Early detection & intervention could change outcomesπŸ‘‰
Tweet media one
0
6
6
@ClinRheumatol
ClinRheumatol
2 months
Let’s harness #AI responsibly to advance knowledge while protecting the integrity of #science! This editorial discusses βœ… Ethical integration of tools like #ChatGPT into #research βœ… Transparency as a cornerstone of scientific integrity βœ… The REFINE process: Review, Evaluate, Formulate, Improve, Nuance, Enhance
Tweet media one
0
6
11
@ClinRheumatol
ClinRheumatol
2 months
πŸ”₯New insights on #BotulinumToxin for #RaynaudsPhenomenon secondary to #Scleroderma! The systematic review reveals significant pain relief & functional improvement πŸ“Œ More research is needed to standardize doses & techniques. πŸ‘‰
Tweet media one
1
13
36
@ClinRheumatol
ClinRheumatol
2 months
Check out the December edition of Clinical Rheumatology! Don't miss the latest articles. πŸ‘‰
Tweet media one
0
5
11
@ClinRheumatol
ClinRheumatol
3 months
New study on CVST in antiphospholipid syndrome πŸ‘‰ 🧠 Severe headache may signal APS-related CVST. ⚠️ Risk factors: contraceptives, infections, malignancies. πŸ’‰ Lifelong anticoagulation reduces recurrence
Tweet media one
0
7
14